Wellgistics Health Aims for 500 New Pharmacies Monthly by 2026
Wellgistics Health provided a corporate outlook for 2026 to stakeholders. "Three months following my return to the role of President at Wellgistics, the Company now has a clear direction as we begin a hyper-focused operational execution phase," said Prashant Patel, interim CEO. "In 2026 we will focus squarely on the implementation of our EinsteinRx AI platform into pharmacy client point of sale systems, onboarding and increasing the percentage of our existing 6,500+ independent pharmacy customers that convert into our official Wellgistics pharmacy network. The key benefit for pharmacies enrolling in the Wellgistics Pharmacy Network will be the integration of patient-specific health information pulled from authorized provider databases with 'just-in-time' prescription optimization tools to empower our network's pharmacists to educate both providers and patients on the best personalized prescription drug selection and prescription drug-adjacent products & services that are associated with the best patient outcomes. We have already started the Wellgistics Pharmacy Network integration process with our closest pharmacy customers and are currently optimizing the onboarding process to make it as seamless as possible for pharmacists, leveraging client feedback to improve speed of deployment and reduce process friction. Once sufficiently optimized, we intend to accelerate the pharmacy conversion marketing effort as we also look to expand our prescription drug manufacturer supplier relationships. We have set a goal of reaching a Wellgistics Pharmacy Network onboarding rate of up to 500 pharmacies per month by year end 2026. While SGLT-2 drug Brenzavvy for the diabetes market is the first product that we are focused on optimizing EinsteinRx for, we intend to quickly expand our branded manufacturer relationships to include other products that primarily target similar patient populations that make up a significant proportion of the patients Wellgistics Pharmacy Network pharmacies serve, including patients who have been prescribed GLP-1 agonist drugs and other drugs associated with cardiometabolic disease, such as Long COVID. Concurrent with this onboarding optimization effort, our technology team has been working to complete its assessment of the resources required to establish PharmacyChain. We will very soon provide updates on this exciting effort that we expect will dramatically improve efficiency in the healthcare delivery market. PharmacyChain is being developed to implement end-to-end smart contracts to drastically reduce the administrative burden associated with optimal healthcare delivery, improve payer transparency and significantly increase the rate of timely insurance reimbursements for pharmacies, providers and other stakeholders in the United States while simultaneously rooting out fraud, waste and abuse in the healthcare system."
Trade with 70% Backtested Accuracy
Analyst Views on WGRX
About WGRX
About the author


Autodesk's Strong Performance: Autodesk Inc reported third-quarter results with adjusted EPS of $2.67 and revenue of $1.85 billion, both exceeding analyst expectations, leading to a 6.1% increase in share price during pre-market trading.
Other Notable Gainers: Mobile-Health Network Solutions surged 45.4%, Inno Holdings gained 29.5%, and KALA Bio increased by 24.1% in pre-market trading, driven by various positive developments and agreements.
Significant Losers: Nutanix Inc saw a 16.8% drop after disappointing financial results and lowered sales guidance, while Biomx Inc and Kaixin Holdings also experienced notable declines of 13.2% and 12.1%, respectively.
Market Overview: The pre-market trading session showed mixed results, with several companies like Urban Outfitters and Petco Health and Wellness reporting better-than-expected earnings, while others faced declines due to poor financial performance.

Avidity Biosciences Acquisition: Avidity Biosciences Inc. shares surged after Novartis AG announced its acquisition of the company for $72.00 per share, a 46% premium over Avidity's closing price on October 24.
Pre-Market Trading Highlights: Several stocks saw significant gains in pre-market trading, including Click Holdings Limited (+173%), Treasure Global Inc (+52.4%), and Banco BBVA Argentina SA (+31.3%).
Notable Stock Declines: Picard Medical, Inc. experienced a sharp decline of 65.3%, while Genenta Science SPA and Wellgistics Health Inc. also saw significant drops of 32.3% and 31.5%, respectively.
Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting both gainers and losers, along with their respective percentage changes.
Wellgistics Health Inc Surge: Wellgistics Health Inc (WGRX) saw its stock price soar over 200% following a collaboration announcement with Datavault AI Inc (DVLT) to integrate blockchain technology into pharmaceutical logistics, attracting significant attention from investors and ETFs focused on AI and healthcare.
Convergence of Technologies: The partnership aligns with a growing trend of merging AI, blockchain, and healthcare innovation, with thematic ETFs like ARK Genomic Revolution ETF and ROBO Global Healthcare Technology and Innovation ETF already capitalizing on this convergence.
PharmacyChain Platform: The collaboration aims to develop the PharmacyChain platform, which will enhance transparency in drug tracking and address longstanding issues in pharmacy logistics, while also exploring a revenue-sharing model for platform usage.
Technological Advancements: This initiative follows Wellgistics' launch of HubRx AI, its proprietary AI platform for pharmacy operations, indicating a strong commitment to leveraging technology for improved efficiency in the healthcare supply chain.
Stock Surge: Wellgistics Health Inc (WGRX) shares have surged over 200% following a strategic partnership announcement with Datavault AI (DVLT) to integrate blockchain technology into its pharmaceutical distribution system.
Partnership Details: The collaboration aims to launch PharmacyChain, a smart contract system for digitizing prescription tracking, enhancing efficiency and patient safety, while also exploring a revenue-sharing model.
Recent Developments: This announcement follows Wellgistics' recent launch of HubRx AI, an AI platform designed for pharmacies, further indicating the company's innovative direction.
Current Stock Performance: As of the latest update, WGRX shares were trading at $1.23, significantly up from a 52-week low of $0.33, reflecting strong market interest.
U.S. Stock Market Performance: U.S. stocks saw significant gains, with the Dow Jones rising over 500 points, while the NASDAQ and S&P 500 also experienced increases of 1.27% and 0.98%, respectively.
Sector Movements: Communication services stocks rose by 1.2%, while energy stocks fell by 0.4%. Notable stock movements included Wellgistics Health surging 229% and Deckers Outdoor Corporation dropping 13%.
Economic Indicators: The University of Michigan consumer sentiment was revised down to 53.6 in October, while the S&P Global services and manufacturing PMIs showed improvements, indicating stronger economic activity.
Global Market Trends: European and Asian markets mostly closed higher, with Japan's Nikkei 225 gaining 1.35% and the eurozone's STOXX 600 rising 0.07%, reflecting a positive global market sentiment.
U.S. Stock Market Performance: U.S. stocks opened higher, with the Nasdaq Composite gaining 1% and the Dow and S&P 500 also showing positive movements. Information technology shares rose by 1.3%, while materials stocks fell by 0.3%.
Procter & Gamble Earnings Report: Procter & Gamble reported better-than-expected earnings and sales for Q3, raising its fiscal 2026 guidance for adjusted EPS and sales, surpassing analyst estimates.
Notable Stock Movements: Wellgistics Health saw a significant increase of 183% after a partnership announcement, while Genenta Science surged 145% due to a collaboration expansion. Conversely, Picard Medical's shares dropped 72%.
Global Market Overview: European shares were mixed, with slight gains in some indices, while Asian markets mostly closed higher. Economic indicators showed an increase in the S&P Global services and manufacturing PMIs for October.









